PACAP 6-38 manufacturers
- PACAP 6-38
-
- $7.00 / 1KG
-
2020-02-14
- CAS:143748-18-9
- Min. Order: 1KG
- Purity: 99%
- Supply Ability: 100kg
|
| | PACAP 6-38 Basic information |
| Product Name: | PACAP 6-38 | | Synonyms: | PHE-THR-ASP-SER-TYR-SER-ARG-TYR-ARG-LYS-GLN-MET-ALA-VAL-LYS-LYS-TYR-LEU-ALA-ALA-VAL-LEU-GLY-LYS-ARG-TYR-LYS-GLN-ARG-VAL-LYS-ASN-LYS-NH2;PITUITARY ADENYLATE ACTIVATING POLYPEPTIDE (6-38) (HUMAN, OVINE, RAT);FTDSYSRYRKQMAVKKYLAAVLGKRYKQRVKNK-NH2;HIS-SER-ASP-GLY-ILE-PHE-THR-AP-SER-TYR-SER-ARG-TYR-ARG-LYS-GLN-MET-ALA-VAL-LYS-LYS-TYR-LEU-ALA-ALA-VAL-LEU-GLY-LYS-ARG-TYR-LYS-GLN-ARG-VAL-LYS-ASN-LYS-NH2;H-PHE-THR-ASP-SER-TYR-SER-ARG-TYR-ARG-LYS-GLN-MET-ALA-VAL-LYS-LYS-TYR-LEU-ALA-ALA-VAL-LEU-GLY-LYS-ARG-TYR-LYS-GLN-ARG-VAL-LYS-ASN-LYS-NH2;PACAP-38 (6-38);PITUITARY ADENYLATE CYCLASE ACTIVATING PEPTIDE (6-38), HUMAN, OVINE, RAT;PITUITARY ADENYLATE CYCLASE ACTIVATING POLYPEPTIDE-38 (6-38) (HUMAN, CHICKEN, MOUSE, OVINE, PORCINE, RAT) | | CAS: | 143748-18-9 | | MF: | C182H300N56O45S | | MW: | 4024.7426 | | EINECS: | | | Product Categories: | Peptide | | Mol File: | 143748-18-9.mol |  |
| | PACAP 6-38 Chemical Properties |
| storage temp. | -15°C | | form | Solid | | Water Solubility | Soluble to 2 mg/ml in water |
| | PACAP 6-38 Usage And Synthesis |
| Uses | PACAP 6-38 is a neuropeptide with antitumor properties. Also functions as a breast cancer PACAP receptor antagonist, inhibitor of growth of the prostate cancer cells | | in vivo | Intravesical administration of the PAC1 receptor antagonist, PACAP (6-38) (300 nM), significantly (p≤0.01) increases intercontraction interval (2.0-fold) and void volume (2.5-fold) in NGF-OE mice. Intravesical instillation of PACAP (6-38) also decreases baseline bladder pressure in NGF-OE mice. Intravesical administration of PACAP (6-38) (300 nM) significantly (p≤0.01) reduces pelvic sensitivity in NGF-OE mice but is without effect in WT mice[3]. | | storage | Store at -20°C |
| | PACAP 6-38 Preparation Products And Raw materials |
|